OverviewChartNewsTraderScreen

UBS Call 115 SNW 21.03.2025/  DE000UP1CQ99  /

Frankfurt Zert./UBS
1/24/2025  7:29:51 PM Chg.+0.001 Bid7:45:35 PM Ask7:45:35 PM Underlying Strike price Expiration date Option type
0.017EUR +6.25% 0.012
Bid Size: 5,000		 0.050
Ask Size: 5,000		 SANOFI SA INHABER ... 115.00 EUR 3/21/2025 Call
TeleTrader 1/23 Europe opens mixed with eyes on Davos forum
TeleTrader 12/31/2024 Europe opens year-end session with losses
TeleTrader 11/22/2024 Europe closes higher, FTSE up over 1%
TeleTrader 10/25/2024 Europe closes mixed amid earnings, data
TeleTrader 10/25/2024 Europe lower in premarket as financial results pour in
TeleTrader 10/25/2024 Sanofi's Q3 net sales up by 15.7% to €13.44 billion
TeleTrader 10/21/2024 Sanofi in talks with CD&R for 50% stake in Opella
GlobeNewswire 9/2/2024 Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to ...
GlobeNewswire 8/26/2024 Latest Dupixent® (dupilumab) and Itepekimab Data at ERS Highlight Scientific Innovation and Leadersh...
GlobeNewswire 8/14/2024 Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering
GlobeNewswire 8/13/2024 Vigil Neuroscience Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 8/12/2024 MeiraGTx Announces $50 Million Offering of Ordinary Shares led by Sanofi and Reports Second Quarter ...
GlobeNewswire 8/12/2024 MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi
GlobeNewswire 8/8/2024 Press Release: Sarclisa induction treatment demonstrated significantly improved progression-free sur...
GlobeNewswire 8/7/2024 Kymera Therapeutics Announces Second Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire 8/6/2024 Alzheimer's Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D ...
GlobeNewswire 8/5/2024 Fierce Biotech Names Recludix Pharma a “Fierce 15” Biotech Company of 2024
GlobeNewswire 8/2/2024 Madrigal Pharmaceuticals Appoints Shannon Kelley as General Counsel
GlobeNewswire 8/1/2024 Denali Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
GlobeNewswire 8/1/2024 Regeneron Reports Second Quarter 2024 Financial and Operating Results
GlobeNewswire 7/31/2024 Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2...
GlobeNewswire 7/25/2024 Press Release: Online availability of Sanofi’s half-year financial report for 2024
TeleTrader 7/25/2024 Europe lower premarket as earnings pour in
TeleTrader 7/25/2024 Sanofi net sales up 7.8% to €10.7B in Q2
GlobeNewswire 7/25/2024 Press Release: Sanofi Q2 - strong performance with 10% sales growth; 2024 guidance upgraded